ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 128687 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 128687; 2) Community: the network communities that were significantly associated with the response to NSC 128687; 3) Molecule: the relationships between components within communities and NSC 128687; 4) MDR: the compounds that were significantly associated with the NSC 128687.

NSC Compound Enrichment Correlation
NSC 683856 Null 0.0072542482863368 0.1438546
NSC 693622 Null 0.0072542482863368 0.23406479
NSC 701555 2,3-Dihydro-1,2-syn-3-[phenylseleno]brefeldin A 0.0072542482863368 -0.077549948
NSC 707148 Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) 0.0072542482863368 0.40227074
NSC 726332 6-[3-((2,2-Dimethoxyethylamino)-1-propyl)]-5,6-dihydro-2,3- dimethoxy-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c] isoquinoline 0.0072542482863368 0.59482885
NSC 747458 Null 0.0072542482863368 0.3659683
NSC 123111 Mitomycin derivative T 53 0.00725424828633685 0.49133129
NSC 105014 Cladribine 0.00741876119839022 0.61223933
NSC 148790 Card-20(22)-enolide, 16-(acetyloxy)-3,14-dihydroxy-, (3.beta.,5.beta.,16.beta.)- (9CI) 0.00741876119839028 0.43650013
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.00741876119839028 0.36858611
Total:87  Current:23    [First] [Prev] [Next] [Last]